After completing the 12-month PGY-2 Pharmacy Residency in Oncology at Mayo Clinic Hospital — Rochester, you will be a proficient practitioner. You will be prepared to provide advanced pharmaceutical care to oncology patients.

The PGY-2 Pharmacy Residency in Oncology at Mayo Clinic Hospital — Rochester builds on Doctor of Pharmacy (PharmD) education. It also builds on PGY-1 pharmacy residency training to develop clinical pharmacists in specialized practice areas. PGY-2 residencies provide opportunities to function independently as a practitioner. You will apply your experience and knowledge to patient care and other advanced practice settings.

Residents who successfully complete an accredited PGY-2 pharmacy residency are prepared for advanced patient care and specialized positions. They are also prepared for academic roles and board certification, if available.

Program highlights

The program provides the high-quality didactic and clinical experiences needed to create a well-rounded, fully competent oncology pharmacist. PGY-2 oncology pharmacy residents:

• Develop expertise, knowledge and skills in oncology therapies
• Contribute to an interdisciplinary health care team by providing patient-specific therapeutic interventions. These interventions help treat, cure, rehabilitate, and alleviate medical conditions and diseases unique to cancer patients
• Enhance skills in conducting clinical research while participating in opportunities at the forefront of cancer care
• Strengthen communication skills by presenting formal and informal lectures to multidisciplinary audiences and learners at all levels. Write a professional manuscript and lead interdisciplinary discussions
• Work with variety of mentors in all facets of residency curriculum to aid in development and career path
• Tailor exceptional hematology/oncology experience to best suit future career goals

Program history

The PGY-2 Pharmacy Residency in Oncology at Mayo Clinic Hospital — Rochester was accredited by the American Society of Health-System Pharmacists (ASHP) in 2003. It has produced respected clinicians who practice across the U.S. The residency program is continuously evaluated for improvement opportunities to ensure graduates make a seamless transition into clinical practice. Three candidates per year are selected on a competitive basis.

Facilities

Mayo Clinic Cancer Center is a National Cancer Institute-designated comprehensive cancer center with an international presence. More than 135,000 people receive cancer treatment at Mayo Clinic each year, making it one of the largest cancer treatment facilities in the nation. Hundreds of clinical trials led by Mayo Clinic physicians and scientists are available for patients, including trials through the Alliance for Clinical Trials in Oncology, Phase I Program, Phase II Consortium and Cancer Prevention Network.

Additional trials are available through cooperative research affiliations and collaborations with the National Cancer Institute and other clinical trial groups. Training for this residency is primarily conducted at Mayo Clinic Hospital — Rochester, though students may have learning experiences at Mayo Clinic's outpatient complex.